Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For:	Brown ET, Martin L, Dmochowski RR. New evidence in the treatment of overactive bladder. Curr Opin Obstet Gynecol 2015;27:366-72. [DOI: 10.1097/gco.0000000000000207] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]

Number

Cited by Other Article(s)

Development and Validation of a Machine Learning Algorithm for Predicting Response to Anticholinergic Medications for Overactive Bladder Syndrome. Obstet Gynecol 2019;134:946-957. [DOI: 10.1097/aog.0000000000003517] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]

Yoshida M, Kakizaki H, Takahashi S, Nagai S, Kurose T. Long-term safety and efficacy of the novel β3-adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study. Int J Urol 2018;25:668-675. [DOI: 10.1111/iju.13596] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2017] [Accepted: 04/03/2018] [Indexed: 12/16/2022]

Yoshida M, Takeda M, Gotoh M, Nagai S, Kurose T. Vibegron, a Novel Potent and Selective β 3 -Adrenoreceptor Agonist, for the Treatment of Patients with Overactive Bladder: A Randomized, Double-blind, Placebo-controlled Phase 3 Study. Eur Urol 2018;73:783-790. [DOI: 10.1016/j.eururo.2017.12.022] [Citation(s) in RCA: 80] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2017] [Accepted: 12/18/2017] [Indexed: 01/16/2023]

Wróbel A, Doboszewska U, Rechberger E, Wlaź P, Rechberger T. SN003, a CRF 1 receptor antagonist, attenuates depressive-like behavior and detrusor overactivity symptoms induced by 13- cis -retinoic acid in rats. Eur J Pharmacol 2017;812:216-224. [DOI: 10.1016/j.ejphar.2017.07.010] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2017] [Revised: 06/29/2017] [Accepted: 07/04/2017] [Indexed: 01/13/2023]